Zeposia as a Treatment for Ulcerative Colitis Shows Positive Results in Phase 3 Trial
source: pixabay.com

Zeposia as a Treatment for Ulcerative Colitis Shows Positive Results in Phase 3 Trial

According to a story from Pharma Advancement, Bristol Myers Squibb recently announced encouraging findings from a phase 3 clinical trial. This study was testing its drug ozanimod (marketed as Zeposia)…

Continue Reading Zeposia as a Treatment for Ulcerative Colitis Shows Positive Results in Phase 3 Trial

 Deferring TAVR Surgery During the COVID-19 Pandemic May Cause Serious Complications

CIDRAP recently featured JAMA NetworkOpen's online reports of two timely research letters. The letters outlined the complications that may arise for aortic stenosis patients who have had to delay transaortic valve…

Continue Reading  Deferring TAVR Surgery During the COVID-19 Pandemic May Cause Serious Complications
Mouse Study Reveals Possible Therapy for Charcot-Marie-Tooth Disease
source: pixabay.com

Mouse Study Reveals Possible Therapy for Charcot-Marie-Tooth Disease

Researchers have recently conducted a study using mouse models of Charcot-Marie-Tooth (CMT) disease, titled "CMTM6 Expressed on the Adaxonal Scwann Cells Surface Restricts Axonal Diameters in Peripheral Nerves." It was…

Continue Reading Mouse Study Reveals Possible Therapy for Charcot-Marie-Tooth Disease

Sorrento Therapeutics Has Received FDA Clearance for STI-1499 Trial in Hospitalized Patients With COVID-19

Waking up to the news has one encouraging note, another new day and another new drug is being tested. According to an article in Biospace, the news from Sorrento Therapeutics…

Continue Reading Sorrento Therapeutics Has Received FDA Clearance for STI-1499 Trial in Hospitalized Patients With COVID-19